• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    GigCapital5, Inc. Announces Closing Date for Business Combination With QT Imaging

    2/29/24 4:45:00 PM ET
    $GIA
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $GIA alert in real time by email

    QT Imaging Holdings, Inc. Expected to Begin Trading on Nasdaq Under Ticker Symbols "QTI" on March 5, 2024

    GigCapital5, Inc. (("GigCapital5", NASDAQ:GIA), a Private-to-Public Equity (PPE)™ entity also known as special purpose acquisition company ("SPAC"), today announced that the completion of their previously announced business combination (the "Business Combination") with QT Imaging, Inc. ("QT Imaging"), a technology company engaged in an innovative automated breast imaging system producing high-resolution transmission ultrasound images, will take place on March 4, 2024. The Business Combination was approved at an Annual Meeting of GigCapital5's stockholders on February 20, 2024. Upon completion of the Business Combination, the combined company will change its name to QT Imaging Holdings, Inc. ("QT Imaging Holdings"). QT Imaging Holdings' shares of common stock are expected to commence trading on the Nasdaq on March 5, 2024 under the new ticker symbols "QTI".

    QT Imaging is a medical device company engaged in the research, development and commercialization of innovative body imaging systems using low energy sound. Supported by a team with well-established roots in the medical device and healthcare industries, QT Imaging's technologies leverage unprecedented detection and monitoring capabilities and premarket FDA clearance, and its safe, affordable, and accessible treatments are poised to tackle critical healthcare challenges with accuracy and precision. The Company is well positioned to leverage the significant growth opportunities in the patient, medical professional, and teaching hospital markets.

    Dr. John Klock, Chief Executive Officer of QT Imaging, said, "The completion of our business combination with GigCapital5 and emergence as a publicly-traded company is a landmark achievement for QT Imaging, and one that we would not have reached without the hard work and focus of our dedicated employees and the support of our partner, GigCapital5."

    Dr. Raluca Dinu, Founding Managing Partner of GigCapital Global and CEO of GigCapital5, said, "The GigCapital team is very proud to have closed our fifth business combination, GigCapital5 with QT Imaging. We stand committed to our mission to guide brilliant teams like QT Imaging as they navigate the journey of becoming a major public enterprise. We are pleased to continue to actively support QT Imaging's growth as part of its Board of Directors and in any other capacity that may be required, as the company enters its next phase of innovation, commercialization, and growth, and we believe it is very well positioned to address rapidly growing customer demand for solutions that augment medical imaging for critical detection, diagnosis, and treatment of disease."

    Dr. Avi Katz, Founding Managing Partner of GigCapital Global and Executive Chairman of the Board of GigCapital5, said, "We are excited about the partnership with QT Imaging. This combination is yet again a successful demonstration of our Private-to-Public Equity (PPE)™ method and our mission to be involved in enterprises that seek to improve the life quality and equality of our planet inhabitants, where we actively partner with leading innovators and differentiators of privately-held high-tech companies on the next chapter of their journey as a fast-growing public company."

    Advisors

    Exit Strategy Partners, LLC introduced the parties and advised QT Imaging, Inc. in the transaction. Brown Rudnick LLP is serving as legal counsel and BPM LLP is serving as auditor to QT Imaging. William Blair is serving as Capital Markets Advisor, DLA Piper LLP (US) is serving as legal counsel, and BPM LLP is serving as auditors to GigCapital5.

    About QT Imaging Holdings

    QT Imaging is a medical device company founded in 2012 and engaged in the research, development, and commercialization of innovative body imaging systems using low energy sound. QT Imaging believes that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable and accessible and its goal is to improve global health outcomes through the development and commercialization of imaging devices that address critical healthcare challenges with accuracy and precision. For more information, please visit: http://QTimaging.com.

    About GigCapital5

    GigCapital5, Inc. is a Private-to-Public Equity (PPE)™ company, also known as a blank check company or special purpose acquisition company (SPAC), focusing on the technology, media and telecommunications (TMT) and sustainable industries. It was sponsored by GigAcquisitions5, LLC, which was founded by GigFounders, LLC, each a member entity of GigCapital Global, and formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses.

    "Private-to-Public Equity (PPE)" is a trademark of GigFounders, LLC, an affiliate GigCapital5, and are used pursuant to agreement.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including the business combination between GigCapital5 and QT Imaging Holdings and the closing of those transactions, and statements regarding QT Imaging Holdings 's management team's expectations, hopes, beliefs, intentions, plans, prospects or strategies regarding the future, including possible business combinations, revenue growth and financial performance, product expansion and services. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on our current expectations and beliefs made by the management of GigCapital5 and QT Imaging in light of their respective experience and their perception of historical trends, current conditions and expected future developments and their potential effects on QT Imaging and GigCapital5 as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting QT Imaging Holdings or GigCapital5 will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including regulatory approvals, the ability of the post-combination company to meet the Nasdaq listing standards, product and service acceptance, and that QT Imaging Holdings will have sufficient capital to operate as anticipated. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Additional factors that could cause actual results to differ are discussed under the heading "Risk Factors" and in other sections of GigCapital5's filings with the SEC, and in GigCapital5's current and periodic reports filed or furnished from time to time with the SEC. All forward-looking statements in this press release are made as of the date hereof, based on information available to GigCapital5 and QT Imaging Holdings as of the date hereof, and GigCapital5 and QT Imaging Holdings assume no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240229352780/en/

    Get the next $GIA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GIA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GIA
    SEC Filings

    See more
    • SEC Form 8-K filed by GigCapital 5 Inc.

      8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

      3/18/24 5:00:32 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • GigCapital 5 Inc. filed SEC Form 8-K: Other Events

      8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

      3/15/24 9:01:02 AM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • GigCapital 5 Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

      8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

      3/8/24 5:04:04 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $GIA
    Leadership Updates

    Live Leadership Updates

    See more
    • Catalyze Partners Appoints Raanan Horowitz to Board of Advisors

      Catalyze Partners has appointed Raanan Horowitz, former CEO of Elbit Systems of America, to its Board of Advisors. With over 30 years of leadership experience across the defense, commercial aviation, and healthcare sectors, Horowitz has a proven track record of driving growth and overseeing strategic acquisitions. Drawing from his extensive experience in scaling companies and navigating complex markets, Horowitz will help Catalyze further develop its portfolio of innovative technology-driven companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241203110969/en/Catalyze Partners adds Raanan Horowitz to its Board of Advisors.

      12/3/24 10:00:00 AM ET
      $BBAI
      $GIA
      Computer Software: Prepackaged Software
      Technology
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $GIA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Budagov Stas

      3 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

      3/8/24 7:36:16 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 3 filed by new insider Weiner Zeev

      3 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

      3/8/24 7:18:19 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 3 filed by new insider Dickson Daniel

      3 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

      3/8/24 7:17:06 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $GIA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Catalyze Partners Appoints Raanan Horowitz to Board of Advisors

      Catalyze Partners has appointed Raanan Horowitz, former CEO of Elbit Systems of America, to its Board of Advisors. With over 30 years of leadership experience across the defense, commercial aviation, and healthcare sectors, Horowitz has a proven track record of driving growth and overseeing strategic acquisitions. Drawing from his extensive experience in scaling companies and navigating complex markets, Horowitz will help Catalyze further develop its portfolio of innovative technology-driven companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241203110969/en/Catalyze Partners adds Raanan Horowitz to its Board of Advisors.

      12/3/24 10:00:00 AM ET
      $BBAI
      $GIA
      Computer Software: Prepackaged Software
      Technology
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • GigCapital5, Inc. Announces Closing Date for Business Combination With QT Imaging

      QT Imaging Holdings, Inc. Expected to Begin Trading on Nasdaq Under Ticker Symbols "QTI" on March 5, 2024 GigCapital5, Inc. (("GigCapital5", NASDAQ:GIA), a Private-to-Public Equity (PPE)™ entity also known as special purpose acquisition company ("SPAC"), today announced that the completion of their previously announced business combination (the "Business Combination") with QT Imaging, Inc. ("QT Imaging"), a technology company engaged in an innovative automated breast imaging system producing high-resolution transmission ultrasound images, will take place on March 4, 2024. The Business Combination was approved at an Annual Meeting of GigCapital5's stockholders on February 20, 2024. Upon co

      2/29/24 4:45:00 PM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • GigCapital5, Inc. Announces Shareholder Approval of Business Combination

      GigCapital5, Inc. ("GigCapital5") (NASDAQ:GIA) today announced that at the Annual Meeting of GigCapital5's stockholders (the "Annual Meeting") held on February 20, 2024, GigCapital5's stockholders voted to approve the previously announced proposed business combination between GigCapital5, QT Imaging, Inc. ("QT Imaging") and QTI Merger Sub, Inc. ("Merger Sub"), as well as all other proposals related to the Business Combination. GigCapital5 plans to file the results of the Annual Meeting, as tabulated by an independent inspector of elections, on Form 8-K with the Securities and Exchange Commission today. About GigCapital5 On December 8, 2022, GigCapital5 entered into a Business Combinat

      2/22/24 9:00:00 AM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $GIA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by GigCapital 5 Inc.

      SC 13D - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

      3/18/24 8:33:56 AM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13D filed by GigCapital 5 Inc.

      SC 13D - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

      3/18/24 8:30:25 AM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G/A filed by GigCapital 5 Inc. (Amendment)

      SC 13G/A - GigCapital5, Inc. (0001844505) (Subject)

      2/22/24 8:39:14 AM ET
      $GIA
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care